RBC Capital lowered the firm’s price target on Thermo Fisher (TMO) to $637 from $651 and keeps an Outperform rating on the shares. The company lowered guidance to reflect the estimated impact from tariff and policy changes, though this lowers the likelihood of further cuts this year, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target lowered to $573 from $603 at Baird
- Thermo Fisher’s Resilience and Strategic Positioning Justify Buy Rating Despite Macroeconomic Challenges
- Thermo Fisher Scientific Reports Strong Q1 2025 Results
- Thermo Fisher Scientific Navigates Strong Q1 Amid Challenges
- Thermo Fisher price target lowered to $610 from $670 at Goldman Sachs
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue